Sclerosing obstructive peritonitis, beta-blockers, and continuous ambulatory peritoneal dialysis.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D001262:Atenolol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008790:Metoprolol / Q000009:adverse effects; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D008790:Metoprolol